These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 14627986)
41. Panhandle PCR: a technical advance to amplify MLL genomic translocation breakpoints. Felix CA; Jones DH Leukemia; 1998 Jun; 12(6):976-81. PubMed ID: 9639429 [TBL] [Abstract][Full Text] [Related]
42. Three-way translocation involves MLL, MLLT3, and a novel cell cycle control gene, FLJ10374, in the pathogenesis of acute myeloid leukemia with t(9;11;19)(p22;q23;p13.3). Vieira L; Sousa AC; Matos P; Marques B; Alaiz H; Ribeiro MJ; Braga P; da Silva MG; Jordan P Genes Chromosomes Cancer; 2006 May; 45(5):455-69. PubMed ID: 16450356 [TBL] [Abstract][Full Text] [Related]
43. Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding. Le H; Singh S; Shih SJ; Du N; Schnyder S; Loredo GA; Bien C; Michaelis L; Toor A; Diaz MO; Vaughan AT Genes Chromosomes Cancer; 2009 Sep; 48(9):806-15. PubMed ID: 19530238 [TBL] [Abstract][Full Text] [Related]
44. Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner gene. Felix CA; Kim CS; Megonigal MD; Slater DJ; Jones DH; Spinner NB; Stump T; Hosler MR; Nowell PC; Lange BJ; Rappaport EF Blood; 1997 Dec; 90(12):4679-86. PubMed ID: 9389682 [TBL] [Abstract][Full Text] [Related]
46. Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research. Reichel M; Gillert E; Breitenlohner I; Repp R; Greil J; Beck JD; Fey GH; Marschalek R Cancer Res; 1999 Jul; 59(14):3357-62. PubMed ID: 10416593 [TBL] [Abstract][Full Text] [Related]
47. Environmental and chemotherapeutic agents induce breakage at genes involved in leukemia-causing gene rearrangements in human hematopoietic stem/progenitor cells. Thys RG; Lehman CE; Pierce LC; Wang YH Mutat Res; 2015 Sep; 779():86-95. PubMed ID: 26163765 [TBL] [Abstract][Full Text] [Related]
48. RAS mutations in pediatric leukemias with MLL gene rearrangements. Mahgoub N; Parker RI; Hosler MR; Close P; Winick NJ; Masterson M; Shannon KM; Felix CA Genes Chromosomes Cancer; 1998 Mar; 21(3):270-5. PubMed ID: 9523205 [TBL] [Abstract][Full Text] [Related]
49. [Mechanism of occurrence of secondary tumors by antitumor drugs]. Andoh T Gan To Kagaku Ryoho; 1999 Nov; 26(13):1988-98. PubMed ID: 10584562 [TBL] [Abstract][Full Text] [Related]
50. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977 [TBL] [Abstract][Full Text] [Related]
51. Complex three-way translocation involving MLL, ELL, RREB1, and CMAHP genes in an infant with acute myeloid leukemia and t(6;19;11)(p22.2;p13.1;q23.3). Tuborgh A; Meyer C; Marschalek R; Preiss B; Hasle H; Kjeldsen E Cytogenet Genome Res; 2013; 141(1):7-15. PubMed ID: 23735562 [TBL] [Abstract][Full Text] [Related]
52. A new case of translocation t(6;11)(q21;q23) in a therapy-related acute myeloid leukemia resulting in an MLL-AF6q21 fusion. Bernard OA; Hillion J; Le Coniat M; Berger R Genes Chromosomes Cancer; 1998 Jul; 22(3):221-4. PubMed ID: 9624533 [TBL] [Abstract][Full Text] [Related]
53. Characterization of t(11;19)(q23;p13.3) by fluorescence in situ hybridization analysis in a pediatric patient with therapy-related acute myelogenous leukemia. Cheng L; Ramesh KH; Radel E; Ratech H; Wei D; Cannizzaro LA Cancer Genet Cytogenet; 2001 Aug; 129(1):17-22. PubMed ID: 11520560 [TBL] [Abstract][Full Text] [Related]
54. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Corral J; Lavenir I; Impey H; Warren AJ; Forster A; Larson TA; Bell S; McKenzie AN; King G; Rabbitts TH Cell; 1996 Jun; 85(6):853-61. PubMed ID: 8681380 [TBL] [Abstract][Full Text] [Related]
55. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Beverloo HB; Le Coniat M; Wijsman J; Lillington DM; Bernard O; de Klein A; van Wering E; Welborn J; Young BD; Hagemeijer A Cancer Res; 1995 Oct; 55(19):4220-4. PubMed ID: 7671224 [TBL] [Abstract][Full Text] [Related]
56. Effects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: a prospective study. Ng A; Taylor GM; Wynn RF; Eden OB Leukemia; 2005 Feb; 19(2):253-9. PubMed ID: 15592432 [TBL] [Abstract][Full Text] [Related]
57. Clustering of genomic breakpoints at the MLL locus in therapy-related acute leukemia with t(4;11)(q21;q23). Hasan SK; Barba G; Metzler M; Divona M; Ottone T; Cicconi L; Falini B; Mecucci C; Lo-Coco F Genes Chromosomes Cancer; 2014 Mar; 53(3):248-54. PubMed ID: 24310817 [TBL] [Abstract][Full Text] [Related]
58. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks. Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535 [TBL] [Abstract][Full Text] [Related]
59. BglII-based panhandle and reverse panhandle PCR approaches increase capability for cloning der(II) and der(other) genomic breakpoint junctions of MLL translocations. Robinson BW; Slater DJ; Felix CA Genes Chromosomes Cancer; 2006 Aug; 45(8):740-53. PubMed ID: 16703585 [TBL] [Abstract][Full Text] [Related]